Emtricitabine with tenofovir disoproxil: Supply issue
Due to a delay at the manufacturing plant, there is a supply issue affecting emtricitabine with tenofovir disoproxil (Pharmacode: 2638088).
Affected product
Viatris, the supplier, advised that there will be a supply issue affecting its brand of emtricitabine with tenofovir disoproxil from late December 2025.
It is used for:
- pre-exposure prophylaxis (PrEP) for HIV
- post-exposure prophylaxis (PEP) for HIV
- treatment of HIV infection in combination with other antiretroviral drugs.
Chemical: Emtricitabine with tenofovir disoproxil
- Presentation: Tab tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg
- Brand: Tenofovir Disoproxil Emtricitabine Viatris
- Pharmacode: 2638088
- Subsidy: $13.45
- Measure / Qty: per 30
Schedule listing for emtricitabine with tenofovir disoproxil(external link)
Alternative product
Pharmac is working on finding an alternative to cover any out-of-stock period.
Resupply expected early 2026
Viatris advises that the New Zealand registered product will be available again early in 2026.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)